Eyepoint Pharmaceuticals Correlations

EYPT Stock

USD 8.25 0.21 2.48%

The current 90-days correlation between Eyepoint Pharmaceuticals and Emergent Biosolutions is 0.24 (i.e., Modest diversification). The correlation of Eyepoint Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Eyepoint Pharmaceuticals Correlation With Market

Weak diversification

The correlation between Eyepoint Pharmaceuticals and DJI is 0.37 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Eyepoint Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eyepoint Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Eyepoint Stock please use our How to Invest in Eyepoint Pharmaceuticals guide.

Moving together with Eyepoint Stock

0.63	ALVO	Alvotech	Pair Corr
0.62	VMD	Viemed Healthcare	Pair Corr

Moving against Eyepoint Stock

0.55	CTLT	Catalent	Pair Corr
0.42	AKAN	Akanda Corp	Pair Corr
0.37	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.35	AHG	Akso Health Group	Pair Corr
0.34	TTOO	T2 Biosystms	Pair Corr
0.42	TNDM	Tandem Diabetes Care	Pair Corr
0.34	HSCSW	Heart Test Laboratories	Pair Corr

Related Correlations Analysis

	EBS	BHC	NBIX	TEVA	HLN	TAK	ITCI	CTLT	AMPH	ALVO
EBS		0.48	0.36	-0.19	-0.64	-0.58	0.58	0.01	-0.03	0.63	EBS
BHC	0.48		0.12	-0.03	-0.46	-0.37	0.55	-0.25	0.3	0.62	BHC
NBIX	0.36	0.12		-0.28	-0.59	-0.58	0.82	0.28	-0.36	-0.2	NBIX
TEVA	-0.19	-0.03	-0.28		0.4	0.44	-0.31	-0.26	0.69	0.16	TEVA
HLN	-0.64	-0.46	-0.59	0.4		0.87	-0.83	0.07	0.32	-0.44	HLN
TAK	-0.58	-0.37	-0.58	0.44	0.87		-0.72	-0.02	0.37	-0.35	TAK
ITCI	0.58	0.55	0.82	-0.31	-0.83	-0.72		-0.06	-0.2	0.24	ITCI
CTLT	0.01	-0.25	0.28	-0.26	0.07	-0.02	-0.06		-0.49	-0.36	CTLT
AMPH	-0.03	0.3	-0.36	0.69	0.32	0.37	-0.2	-0.49		0.4	AMPH
ALVO	0.63	0.62	-0.2	0.16	-0.44	-0.35	0.24	-0.36	0.4		ALVO
	EBS	BHC	NBIX	TEVA	HLN	TAK	ITCI	CTLT	AMPH	ALVO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

TAK	+ 0.87	HLN
ITCI	+ 0.82	NBIX
AMPH	+ 0.69	TEVA
ALVO	+ 0.63	EBS
ALVO	+ 0.62	BHC
ITCI	+ 0.58	EBS

High negative correlations

ITCI	- 0.83	HLN
ITCI	- 0.72	TAK
HLN	- 0.64	EBS
HLN	- 0.59	NBIX
TAK	- 0.58	NBIX
TAK	- 0.58	EBS

Risk-Adjusted Indicators

There is a big difference between Eyepoint Stock performing well and Eyepoint Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Eyepoint Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
EBS	4.49	0.03	0.04	0.12	5.42	(4.57)	11.40	(8.45)	39.28
BHC	2.29	0.34	0.09	7.88	2.36	(2.85)	6.30	(3.83)	19.18
NBIX	1.13	(0.01)	0.00	0.10	1.33	(1.22)	2.74	(2.01)	11.43
TEVA	1.33	0.07	(0.06)	0.00	1.88	(1.30)	2.63	(2.23)	12.42
HLN	0.74	(0.13)	0.00	(1.03)	0.00	0.00	1.10	(1.40)	4.53
TAK	0.75	(0.10)	0.00	1.58	0.00	0.00	1.28	(2.02)	4.86
ITCI	1.33	0.11	0.06	0.24	1.52	(1.47)	3.04	(2.53)	16.17
CTLT	0.46	0.04	(0.08)	0.21	0.31	(0.53)	1.12	(0.69)	3.39
AMPH	1.58	(0.13)	(0.04)	0.00	2.84	(1.64)	3.37	(2.51)	17.30
ALVO	1.19	0.07	(0.04)	(0.34)	1.42	(1.38)	3.15	(2.82)	8.63

Eyepoint Pharmaceuticals Corporate Management

David Jones	Senior Officer	Profile
Jay MD	Chief Officer	Profile
Michael Pine	Chief Officer	Profile
Ramiro MD	Chief Officer	Profile
Jennifer Leonard	Chief IT	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC